+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oncology NGS Market by Product Type, Cancer Type, Application, End User - Global Forecast to 2030- Product Image
Oncology NGS Market by Product Type, Cancer Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Oncology NGS Market by Product Type, Cancer Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715540
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The oncology next-generation sequencing (NGS) market is undergoing rapid transformation as advances in genomic technologies reshape cancer diagnostics, personalized therapies, and research worldwide. Senior leaders are seeking actionable intelligence to navigate evolving technologies, regulatory environments, and competitive landscapes fueling this sector.

Market Snapshot: Oncology NGS Market Growth

The Oncology NGS Market grew from USD 504.37 million in 2024 to USD 583.57 million in 2025. It is expected to continue expanding at a CAGR of 15.57%, reaching USD 1.20 billion by 2030. This growth reflects strong technological momentum, investments in precision medicine, and increasing integration of genomic profiling in clinical pathways.

Scope & Segmentation: Market Coverage and Focus Areas

  • Product Types: Platforms, reagents and consumables, and sequencing services drive market activity. This includes benchtop and high-throughput sequencers, flow cells, library preparation, sequencing kits, and expert services for data analysis and sample preparation.
  • Cancer Types: Applications span breast cancer, colorectal cancer, hematological malignancies, and lung cancer, reflecting varied clinical adoption patterns based on biomarker panels and reimbursement frameworks.
  • Applications: Gene panels dominate targeted therapy strategies, while RNA sequencing and whole exome sequencing enable deeper insights for both prevalent and rare cancers.
  • End Users: Academic institutes, diagnostic laboratories, hospitals, and pharmaceutical or biotech companies each leverage NGS to advance cancer discovery, patient management, and therapy development.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific are all represented. Key sub-regions include the United States (including California, Texas, New York, among others), Canada, Brazil, United Kingdom, Germany, Saudi Arabia, South Africa, China, India, Japan, Australia, and several others.
  • Technology Trends: Adoption is fueled by long-read and single-cell sequencing, AI-empowered data analytics, cloud-based collaboration, liquid biopsy approaches, and flexible automation supporting both research and clinical settings.
  • Company Coverage: Leading vendors and innovators such as Illumina, Thermo Fisher Scientific, Roche, BGI Genomics, QIAGEN, Agilent Technologies, PerkinElmer, Eurofins Scientific, Guardant Health, and Sophia Genetics.

Key Takeaways: Strategic Insights for Decision-Makers

  • The oncology NGS market is moving from a research-centric phase to a central pillar of clinical oncology, with applications in both diagnostics and therapeutic support.
  • Emerging technologies—including single-cell and long-read sequencing—are unlocking more complex cancer genomics, improving detection of tumor heterogeneity and rare events.
  • AI-driven analytics accelerate the interpretation of large-scale genomic data, supporting faster clinical decisions and the development of companion diagnostics.
  • Integrated solutions and strategic partnerships between instrument manufacturers, reagent suppliers, and data analytics firms are streamlining workflows, enabling scalable operations for laboratories and clinical trial networks.
  • Regional market dynamics vary, with the Americas benefiting from established reimbursement and infrastructure, while Asia-Pacific and select EMEA countries are building momentum through investment in domestic innovation.
  • Regulatory adaptability is crucial, as agencies shift toward frameworks that recognize both analytical and clinical utility, fostering faster adoption of new sequencing technologies.

Tariff Impact: Navigating Trade Policy Shifts

New U.S. tariffs introduced in 2025 have raised costs for imported sequencers and consumables, prompting laboratories and suppliers to adapt. Strategies include localizing manufacturing, renegotiating supply contracts, and reprioritizing research budgets. In the longer term, these shifts are seen as opportunities to strengthen domestic supply chains and achieve greater market resilience.

Methodology & Data Sources

Research methods combined extensive secondary review of peer-reviewed literature, regulatory records, corporate documentation, and patent databases. Primary data included targeted interviews with laboratory and clinical experts, payers, and genomics industry stakeholders, ensuring balanced, validated market estimates and coded trends.

Why This Report Matters: Actionable Value for B2B Leaders

  • Gain strategic clarity on evolving technologies, adoption drivers, and regulatory shifts shaping the oncology NGS market landscape.
  • Identify actionable opportunities across product types, cancer applications, user segments, and regions—enabling data-driven investment and go-to-market planning.
  • Equip your organization to anticipate tariff impacts, mitigate supply chain risk, and accelerate collaboration with leading industry partners.

Conclusion

As next-generation sequencing cements its role in cancer care, the future will be defined by agile technology integration and cross-sector partnerships. This report provides senior decision-makers with the insights needed to lead, adapt, and capitalize on emerging opportunities in a dynamic oncology NGS market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oncology NGS Market, by Product Type
8.1. Introduction
8.2. Platforms
8.2.1. Benchtop Sequencers
8.2.2. High Throughput Sequencers
8.3. Reagents and Consumables
8.3.1. Flow Cells
8.3.2. Library Prep Kits
8.3.3. Sequencing Kits
8.4. Services
8.4.1. Data Analysis Services
8.4.2. Sample Preparation Services
9. Oncology NGS Market, by Cancer Type
9.1. Introduction
9.2. Breast Cancer
9.3. Colorectal Cancer
9.4. Hematological Malignancies
9.5. Lung Cancer
10. Oncology NGS Market, by Application
10.1. Introduction
10.2. Gene Panels
10.3. Rna Sequencing
10.4. Whole Exome Sequencing
11. Oncology NGS Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals
11.5. Pharma and Biotech Companies
12. Americas Oncology NGS Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Oncology NGS Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Oncology NGS Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Illumina, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Roche Holding AG
15.3.4. BGI Genomics Co., Ltd.
15.3.5. QIAGEN N.V.
15.3.6. Agilent Technologies, Inc.
15.3.7. PerkinElmer, Inc.
15.3.8. Eurofins Scientific SE
15.3.9. Guardant Health, Inc.
15.3.10. Sophia Genetics SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ONCOLOGY NGS MARKET MULTI-CURRENCY
FIGURE 2. ONCOLOGY NGS MARKET MULTI-LANGUAGE
FIGURE 3. ONCOLOGY NGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ONCOLOGY NGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HIGH THROUGHPUT SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GENE PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 52. CANADA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 53. CANADA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 54. CANADA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. FRANCE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 102. FRANCE ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 103. FRANCE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. FRANCE ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 105. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. FRANCE ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. ITALY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 116. ITALY ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 117. ITALY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. ITALY ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 119. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ITALY ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. SPAIN ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. SPAIN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 123. SPAIN ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. DENMARK ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 151. DENMARK ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. QATAR ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 165. QATAR ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 166. QATAR ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 167. QATAR ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. QATAR ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. FINLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 195. EGYPT ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. EGYPT ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. TURKEY ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. TURKEY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 200. TURKEY ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 201. TURKEY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 202. TURKEY ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. TURKEY ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. NORWAY ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. POLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 221. POLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 222. POLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 223. POLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 224. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. POLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 241. CHINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. CHINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 243. CHINA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 244. CHINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. CHINA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 246. CHINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. CHINA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. INDIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. INDIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 250. INDIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 251. INDIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 252. INDIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. INDIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. JAPAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 259. JAPAN ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 260. JAPAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. JAPAN ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. THAILAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. THAILAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 285. THAILAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. THAILAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 287. THAILAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 288. THAILAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. THAILAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 326. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Oncology NGS market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Roche Holding AG
  • BGI Genomics Co., Ltd.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Eurofins Scientific SE
  • Guardant Health, Inc.
  • Sophia Genetics SA

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 583.57 Million
Forecasted Market Value ( USD ) by 2030 $ 1200 Million
Compound Annual Growth Rate15.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

NGS Sample Preparation Market by Product Type, Application, Technology, Workflow Step, End User - Global Forecast to 2030 - Product Image

NGS Sample Preparation Market by Product Type, Application, Technology, Workflow Step, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
NGS Library Preparation Automation Market by Product Type, Application, Automation, End User - Global Forecast to 2030 - Product Image

NGS Library Preparation Automation Market by Product Type, Application, Automation, End User - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
NGS-based RNA-sequencing Market Size, Share & Trends Analysis Report by Product & Service (Consumables, Instruments, Services), Workflow (Pre-sequencing, Sequencing, Data Analysis), Application, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

NGS-based RNA-sequencing Market Size, Share & Trends Analysis Report by Product & Service (Consumables, Instruments, Services), Workflow (Pre-sequencing, Sequencing, Data Analysis), Application, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029 - Product Image

Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029

  • Report
  • 152 Pages
  • Global
From
Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report - Product Image

Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report

  • Report
  • 206 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.